🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-522543-18-00
Completed Phase I

A Phase 1/1b First-in-Human Study of BMS-986506 in ccRCC

2025-522543-18-00 · tracked via the Priya Life Science EU tracker
Sponsor
Bristol-Myers Squibb Services Unlimited Company
Sponsor type
Pharmaceutical company
Therapeutic area
Neoplasms
Decision date
09/02/2026
Enrollment target
48
Sites
Spain, France

Condition studied

Advanced Clear Cell Renal Cell Carcinoma

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-522543-18-00 on CTIS ↗ ← All trials in the EU